609 related articles for article (PubMed ID: 32812139)
1. Considerations in the Development of Small-Diameter Vascular Graft as an Alternative for Bypass and Reconstructive Surgeries: A Review.
Obiweluozor FO; Emechebe GA; Kim DW; Cho HJ; Park CH; Kim CS; Jeong IS
Cardiovasc Eng Technol; 2020 Oct; 11(5):495-521. PubMed ID: 32812139
[TBL] [Abstract][Full Text] [Related]
2. The applications of heparin in vascular tissue engineering.
Aslani S; Kabiri M; HosseinZadeh S; Hanaee-Ahvaz H; Taherzadeh ES; Soleimani M
Microvasc Res; 2020 Sep; 131():104027. PubMed ID: 32505610
[TBL] [Abstract][Full Text] [Related]
3. Advancing tissue-engineered vascular grafts via their endothelialization and mechanical conditioning.
Antonyshyn JA; D'''''Costa KA; Santerre JP
J Cardiovasc Surg (Torino); 2020 Oct; 61(5):555-576. PubMed ID: 32909708
[TBL] [Abstract][Full Text] [Related]
4. Experimental noninferiority trial of synthetic small-caliber biodegradable versus stable vascular grafts.
Mugnai D; Tille JC; Mrówczyński W; de Valence S; Montet X; Möller M; Walpoth BH
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):400-7.e1. PubMed ID: 23098749
[TBL] [Abstract][Full Text] [Related]
5. Patency and in vivo compatibility of bacterial nanocellulose grafts as small-diameter vascular substitute.
Weber C; Reinhardt S; Eghbalzadeh K; Wacker M; Guschlbauer M; Maul A; Sterner-Kock A; Wahlers T; Wippermann J; Scherner M
J Vasc Surg; 2018 Dec; 68(6S):177S-187S.e1. PubMed ID: 29248244
[TBL] [Abstract][Full Text] [Related]
6. Antithrombogenic modification of small-diameter microfibrous vascular grafts.
Hashi CK; Derugin N; Janairo RR; Lee R; Schultz D; Lotz J; Li S
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1621-7. PubMed ID: 20466974
[TBL] [Abstract][Full Text] [Related]
7. Tissue engineered small-diameter vascular grafts.
Schmedlen RH; Elbjeirami WM; Gobin AS; West JL
Clin Plast Surg; 2003 Oct; 30(4):507-17. PubMed ID: 14621299
[TBL] [Abstract][Full Text] [Related]
8. Sustained Thromboresistant Bioactivity with Reduced Intimal Hyperplasia of Heparin-Bonded Polytetrafluoroethylene Propaten Graft in a Chronic Canine Femoral Artery Bypass Model.
Freeman J; Chen A; Weinberg RJ; Okada T; Chen C; Lin PH
Ann Vasc Surg; 2018 May; 49():295-303. PubMed ID: 29197605
[TBL] [Abstract][Full Text] [Related]
9. Bioresorbable silk grafts for small diameter vascular tissue engineering applications: In vitro and in vivo functional analysis.
Gupta P; Lorentz KL; Haskett DG; Cunnane EM; Ramaswamy AK; Weinbaum JS; Vorp DA; Mandal BB
Acta Biomater; 2020 Mar; 105():146-158. PubMed ID: 31958596
[TBL] [Abstract][Full Text] [Related]
10. Biological mechanisms influencing prosthetic bypass graft patency: possible targets for modern graft design.
Scharn DM; Daamen WF; van Kuppevelt TH; van der Vliet JA
Eur J Vasc Endovasc Surg; 2012 Jan; 43(1):66-72. PubMed ID: 22001149
[TBL] [Abstract][Full Text] [Related]
11. Biofabrication of small diameter tissue-engineered vascular grafts.
Weekes A; Bartnikowski N; Pinto N; Jenkins J; Meinert C; Klein TJ
Acta Biomater; 2022 Jan; 138():92-111. PubMed ID: 34781026
[TBL] [Abstract][Full Text] [Related]
12. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
[TBL] [Abstract][Full Text] [Related]
13. Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery.
Chlupáč J; Filová E; Bačáková L
Physiol Res; 2009; 58 Suppl 2():S119-S140. PubMed ID: 20131930
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
[TBL] [Abstract][Full Text] [Related]
15. Long-term patency of small-diameter vascular graft made from fibroin, a silk-based biodegradable material.
Enomoto S; Sumi M; Kajimoto K; Nakazawa Y; Takahashi R; Takabayashi C; Asakura T; Sata M
J Vasc Surg; 2010 Jan; 51(1):155-64. PubMed ID: 19954921
[TBL] [Abstract][Full Text] [Related]
16. Improvement of patency rate in heparin-coated small synthetic vascular grafts.
Walpoth BH; Rogulenko R; Tikhvinskaia E; Gogolewski S; Schaffner T; Hess OM; Althaus U
Circulation; 1998 Nov; 98(19 Suppl):II319-23; discussion II324. PubMed ID: 9852921
[TBL] [Abstract][Full Text] [Related]
17. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
Ishii Y; Sakamoto S; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Hill JG; Damiano RJ
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1237-45; discussion 1245-6. PubMed ID: 18544361
[TBL] [Abstract][Full Text] [Related]
18. Rapid Self-Assembly of Bioengineered Cardiovascular Bypass Grafts From Scaffold-Stabilized, Tubular Bilevel Cell Sheets.
von Bornstädt D; Wang H; Paulsen MJ; Goldstone AB; Eskandari A; Thakore A; Stapleton L; Steele AN; Truong VN; Jaatinen K; Hironaka C; Woo YJ
Circulation; 2018 Nov; 138(19):2130-2144. PubMed ID: 30474423
[TBL] [Abstract][Full Text] [Related]
19. Effect of implantation site on outcome of tissue-engineered vascular grafts.
Sologashvili T; Saat SA; Tille JC; De Valence S; Mugnai D; Giliberto JP; Dillon J; Yakub A; Dimon Z; Gurny R; Walpoth BH; Moeller M
Eur J Pharm Biopharm; 2019 Jun; 139():272-278. PubMed ID: 31004790
[TBL] [Abstract][Full Text] [Related]
20. Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model.
Fukunishi T; Best CA; Sugiura T; Opfermann J; Ong CS; Shinoka T; Breuer CK; Krieger A; Johnson J; Hibino N
J Thorac Cardiovasc Surg; 2017 Apr; 153(4):924-932. PubMed ID: 27938900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
